Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge.
Woldemeskel BA, Garliss CC, Aytenfisu TY, Johnston TS, Beck EJ, Dykema AG, Frumento N, Wright DA, Yang AH, Damanakis AI, Laeyendecker O, Cox AL, Mostafa HH, Karaba AH, Blankson JN. Woldemeskel BA, et al. Among authors: laeyendecker o. JCI Insight. 2022 May 23;7(10):e159474. doi: 10.1172/jci.insight.159474. JCI Insight. 2022. PMID: 35389888 Free PMC article.
Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening.
Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke MA, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J Jr, Mannheimer S, Del Rio C, Kuo I, Harawa NT, Koblin BA, Moore R, Blankson JN, Eshleman SH. Piwowar-Manning E, et al. Among authors: laeyendecker o. HIV Clin Trials. 2014 Mar-Apr;15(2):62-8. doi: 10.1310/hct1502-62. HIV Clin Trials. 2014. PMID: 24710920 Free PMC article. Clinical Trial.
Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection.
Patel EU, Cox AL, Mehta SH, Boon D, Mullis CE, Astemborski J, Osburn WO, Quinn J, Redd AD, Kirk GD, Thomas DL, Quinn TC, Laeyendecker O. Patel EU, et al. Among authors: laeyendecker o. J Infect Dis. 2016 Aug 1;214(3):344-52. doi: 10.1093/infdis/jiw005. Epub 2016 Jan 14. J Infect Dis. 2016. PMID: 26768250 Free PMC article.
Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
Kirkpatrick AR, Patel EU, Celum CL, Moore RD, Blankson JN, Mehta SH, Kirk GD, Margolick JB, Quinn TC, Eshleman SH, Laeyendecker O. Kirkpatrick AR, et al. Among authors: laeyendecker o. AIDS Res Hum Retroviruses. 2016 Aug;32(8):756-62. doi: 10.1089/AID.2015.0198. Epub 2016 May 5. AIDS Res Hum Retroviruses. 2016. PMID: 26988426 Free PMC article.
Short Communication: The Impact of Viral Suppression and Viral Breakthrough on Limited-Antigen Avidity Assay Results in Individuals with Clade B HIV Infection.
Wendel SK, Longosz AF, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Quinn TC, Laeyendecker O. Wendel SK, et al. Among authors: laeyendecker o. AIDS Res Hum Retroviruses. 2017 Apr;33(4):325-327. doi: 10.1089/AID.2016.0105. Epub 2017 Jan 11. AIDS Res Hum Retroviruses. 2017. PMID: 27875908 Free PMC article.
Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.
Walker-Sperling VE, Pohlmeyer CW, Veenhuis RT, May M, Luna KA, Kirkpatrick AR, Laeyendecker O, Cox AL, Carrington M, Bailey JR, Arduino RC, Blankson JN. Walker-Sperling VE, et al. Among authors: laeyendecker o. EBioMedicine. 2017 Feb;16:141-149. doi: 10.1016/j.ebiom.2017.01.034. Epub 2017 Jan 26. EBioMedicine. 2017. PMID: 28159573 Free PMC article.
310 results